Related Experiment Video
Updated: Sep 8, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.6K
Building Blocks for the Screening of Histone Deacetylase Inhibitors Using μSPOT
Carlos Moreno-Yruela1, Vita Sereikaite2
1Laboratory of Biophysical Chemistry of Macromolecules (LCBM), Institute of Chemical Sciences and Engineering (ISIC), School of Basic Sciences (SB), EPFL, Lausanne, Switzerland. carlos.morenoyruela@epfl.ch.
Methods in Molecular Biology (Clifton, N.J.)
|July 15, 2025
Summary
Researchers developed a new method to create selective histone deacetylase (HDAC) inhibitors. This approach enables the screening of diverse peptide libraries for potential cancer therapies and treatments for other diseases.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Drug Discovery
Background:
- Histone deacetylase (HDAC) inhibitors are utilized in cancer chemotherapy and investigated for other diseases.
- A significant gap exists in isozyme-selective HDAC inhibitors, hindering the understanding of individual HDAC functions and the development of drugs for broader applications.
Purpose of the Study:
- To synthesize novel hydroxamic acid and trifluoromethyl ketone building blocks.
- To utilize these building blocks for creating diverse libraries of HDAC-binding peptides.
- To establish a method for efficient screening of these peptide libraries for HDAC inhibitory activity and selectivity.
Main Methods:
- Synthesis of hydroxamic acid and trifluoromethyl ketone building blocks.
- Peptide library synthesis using the SPOT method on cellulose discs.
- Deprotection and solubilization to create printable DMSO stocks.
- Screening of peptide libraries on assay-ready slides for HDAC inhibition.
Main Results:
- Successfully synthesized novel building blocks for HDAC inhibitor development.
- Generated diverse peptide libraries with potential HDAC-binding capabilities.
- Demonstrated a method allowing multiple screening rounds on a single library.
- Identified compounds active in cellular assays, exhibiting diverse selectivity.
Conclusions:
- The developed method facilitates the efficient screening of peptide libraries for HDAC inhibitors.
- This approach aids in the discovery of isozyme-selective HDAC inhibitors.
- The findings provide a platform for developing novel therapeutics for a wider range of disorders beyond cancer.
Keywords:
EpigeneticsHDACHigh-throughput screeningHistone deacetylaseHydroxamic acidInhibitorPeptide microarrayTrifluoromethyl ketoneμSPOT
